Bora Navigates A Transitional 1Q26 And Sets A Strong Foundation For Rest Of The Year
Transformational Acquisitions Expected to Contribute to Long Term Growth Starting 2Q26 HONG KONG SAR - Media OutReach Newswire – 13 May 2026 – Bora Pharmaceuticals ("Bora"; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 1Q2026 and provides full year outlook . 1Q26 Business and Financial Highlights The Company reported 1Q26 revenues of NT$4,001 millio...
read full article
